This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.
| Registry number | NCT00672074 |
|---|---|
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | Helsinn Therapeutics (U.S.), Inc |
| Enrollment | 117 participants |
| Design | Interventional, Randomized, Parallel, Masking: Quadruple |
| Conditions | Ileus |
| Interventions | Ipamorelin; placebo |
| Start | Apr 2008 |
| Primary completion | Dec 2009 |
| Study completion | Dec 2009 |
| Results posted | Not yet |
| Registry last updated | Apr 14, 2017 |
Compounds on this site that cite this trial
What the registry says the trial is about
The purpose of this study is to determine if ipamorelin is safe and effective in the management of post-operative ileus.
Primary outcomes
These are what the trial was designed to measure first. They are registered in advance, which is what makes a later result checkable.
| Outcome measure | Time frame |
|---|---|
| Recovery of GI function | Until hospital discharge |
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Last checked against the registry on Oct 3, 2026. See the trial changes feed for what has changed recently.
